NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 04/30/26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 04/30/26 | DEF 14A | Definitive proxy statements |
|
|
39 |
| 04/30/26 | SCHEDULE 13G | Statement of Beneficial Ownership by Certain Investors |
|
4 | |
| 04/24/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 04/24/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 04/24/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 04/21/26 | 8-K | Current report |
|
|
6 |
| 04/06/26 | SCHEDULE 13G/A | Statement of Beneficial Ownership by Certain Investors |
|
4 | |
| 03/26/26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] |
|
|
110 |
| 03/25/26 | 8-K | Current report |
|
|
11 |



